{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-072864","form_type":"8-K","ticker":null,"cik":"0001628945","company_name":"Cue Health Inc.","filed_at":"2024-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.864880+00:00","generated_at":"2026-06-04T11:38:48.753249+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cue Health CEO Ayub Khattak steps down; co-founder Clint Sever appointed CEO","bullets":["Ayub Khattak resigned as CEO, President, and Chairman effective March 19, 2024; remains on board.","Co-founder Clint Sever, previously Chief Product Officer, appointed CEO effective March 20, 2024.","Board appointed Dr. Paul Brown (ex-Roche Molecular) and Dr. Lisa Danzig (ex-Grifols) as strategic advisors.","Company will initiate comprehensive business and operational review to refine strategy and reduce costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-072864","json":"https://secwatch.observer/filing/0001193125-24-072864.json","markdown":"https://secwatch.observer/filing/0001193125-24-072864.md","text":"https://secwatch.observer/filing/0001193125-24-072864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628945/000119312524072864/0001193125-24-072864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628945/000119312524072864/d789392d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T11:38:48.753249+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3060ee7c9c","claim":"Clint Sever was appointed as Chief Executive Officer at Cue Health Inc..","evidence_excerpt":"On March 20, 2024, the Company appointed co-founder and current Chief Product Officer, Clint Sever, as Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628945/000119312524072864/0001193125-24-072864-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a1218100e5","claim":"Ayub Khattak departed as Chief Executive Officer, President and Chairman of the Board at Cue Health Inc..","evidence_excerpt":"On March 19, 2024, Cue Health Inc. (the “Company”) announced that Ayub Khattak is stepping down as Chief Executive Officer, President and Chairman of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628945/000119312524072864/0001193125-24-072864-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Executive Officer, President and Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}